Reneo Pharmaceuticals
ID: 7647902Reneo Pharmaceuticals is a Genetically-Defined Orphan Therapies.
2
Funding Rounds
$145.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro***** Bl*** | - | - | - |
| Er** Du** | - | - | - |
| St**** Se***** | - | - | |
| Pa** W. Ho******* | - | - | |
| Gr***** J. Fl***** | - | - | - |
| Ni*** O'******* | - | - | - |
| Ed Ma***** | - | - | |
| Mi** Gr** | - | - | - |
| Ba** Mu******** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Reneo Pharmaceuticals has raised a total of $145m in funding over 2 rounds.
Key Insights:
- Reneo Pharmaceuticals Series B round, December 2020: $95m
- Reneo Pharmaceuticals Series A round, May 2019: $50m
Industries
Reneo Pharmaceuticals is active in the following industries: